RecruitingNCT07227038
Living Well With Advanced Breast Cancer
Sponsor
Ohio State University Comprehensive Cancer Center
Enrollment
50 participants
Start Date
Jan 13, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study evaluates the use of supportive care in patients with advanced breast cancer to better understand what has helped them, what has been hard, and what kind of help they still need.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study looks at a special clinic program called "Living Well With Advanced Breast Cancer" (LWABC) to understand what helps patients with stage 4 metastatic breast cancer access supportive care and quality-of-life services. It includes patients, those who declined the program, and caregivers.
**You may be eligible if...**
- You are 18 or older with a diagnosis of stage 4 metastatic breast cancer within the past 5 years (patients)
- You are a caregiver for someone with advanced breast cancer
- You have either attended, been referred to, or cancelled an appointment with the LWABC program
**You may NOT be eligible if...**
- You cannot provide your own informed consent
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERNon-Interventional Study
Non-interventional study
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07227038
Related Trials
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
NCT05564377479 locations
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
NCT011741211 location
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
NCT0360696730 locations
Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer
NCT064340641 location
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
NCT059698602 locations